Novo Nordisk’s GLP-1 Drug Fails to Quell Alzheimer’s in Recent Trials
Criteria and Comparisons Used in the Trials The trials were designed with specific parameters to ensure the relevance of the results. Participants included individuals diagnosed with early-stage Alzheimer’s, aiming to test not only safety but also the therapeutic benefits of the GLP-1 medication. Image – via Pixabay Inclusion and Exclusion Criteria for Participants To create … Read more